Treatment of acute and transient psychotic disorders with low and high doses of oral haloperidol
- PMID: 21584060
- PMCID: PMC2967098
Treatment of acute and transient psychotic disorders with low and high doses of oral haloperidol
Abstract
The apparent rationale for the popular use of high doses of neuroleptics in psychotic patients is to increase the degree and speed of therapeutic response .However, several recent reports have questioned these claims. The present study was undertaken with the aim to compare the efficacy of high and low oral doses of haloperidol in the treatment of acute and transient psychotic disorders. The sample comprised of forty patients of both sexes diagnosed as acute and transient psychotic disorder who were randomly assigned to high dose (20 mg/day) and low dose (5 mg /day) haloperidol groups with equal number of subjects (n=20) in both groups. Weekly assessment was done on Brief Psychiatric Rating Scale and Haloperidol Side-effects Check List (day 7, 14, 21, 28, 35 & 42). Both groups showed significant improvement in BPRS from baseline scores on all assessments. Comparison of the improvement rate in both study groups revealed no significant difference.
Keywords: Oral haloperidol; acute and transient psychotic disorders; high dose; low dose.
Similar articles
-
An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.J Clin Psychopharmacol. 1998 Aug;18(4):296-304. doi: 10.1097/00004714-199808000-00009. J Clin Psychopharmacol. 1998. PMID: 9690695 Clinical Trial.
-
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.Psychopharmacology (Berl). 2005 Apr;178(4):514-23. doi: 10.1007/s00213-004-2082-5. Epub 2005 Jan 14. Psychopharmacology (Berl). 2005. PMID: 15650846 Clinical Trial.
-
Quetiapine : A Review of its Use in Schizophrenia.CNS Drugs. 1998 Apr;9(4):325-40. doi: 10.2165/00023210-199809040-00007. CNS Drugs. 1998. PMID: 27521016
-
Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. doi: 10.1097/00004850-199705002-00004. Int Clin Psychopharmacol. 1997. PMID: 9218163 Review.
-
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.J Psychiatry Neurosci. 1994 Jul;19(4):254-64. J Psychiatry Neurosci. 1994. PMID: 7918346 Free PMC article. Review.
Cited by
-
The predictive validity and outcome of ICD-10 and DSM-5 short-lived psychotic disorders: a review and meta-analysis.Eur Arch Psychiatry Clin Neurosci. 2022 Oct;272(7):1157-1168. doi: 10.1007/s00406-021-01356-7. Epub 2022 Jan 6. Eur Arch Psychiatry Clin Neurosci. 2022. PMID: 34988647 Review.
-
Acute and transient psychotic disorders: A review of Indian research.Indian J Psychiatry. 2023 Sep;65(9):895-913. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_254_23. Epub 2023 Sep 5. Indian J Psychiatry. 2023. PMID: 37841545 Free PMC article. Review.
-
Haloperidol dose for the acute phase of schizophrenia.Cochrane Database Syst Rev. 2013 Aug 28;2013(8):CD001951. doi: 10.1002/14651858.CD001951.pub2. Cochrane Database Syst Rev. 2013. PMID: 23983042 Free PMC article.
-
Acute and Transient Psychotic Disorders: Newer Understanding.Curr Psychiatry Rep. 2019 Nov 4;21(11):113. doi: 10.1007/s11920-019-1099-8. Curr Psychiatry Rep. 2019. PMID: 31686264 Review.
References
LinkOut - more resources
Full Text Sources